Polymeric micelles for breast cancer therapy: recent updates, clinical translation and regulatory considerations

V Junnuthula, P Kolimi, D Nyavanandi, S Sampathi… - Pharmaceutics, 2022 - mdpi.com
With the growing burden of cancer, parallel advancements in anticancer nanotechnological
solutions have been witnessed. Among the different types of cancers, breast cancer …

Advancement in solubilization approaches: a step towards bioavailability enhancement of poorly soluble drugs

L Kumari, Y Choudhari, P Patel, GD Gupta, D Singh… - Life, 2023 - mdpi.com
A drug's aqueous solubility is defined as the ability to dissolve in a particular solvent, and it
is currently a major hurdle in bringing new drug molecules to the market. According to some …

Revisiting supersaturation of a biopharmaceutical classification system IIB drug: Evaluation via a multi-cup dissolution approach and molecular dynamic simulation

Y Gan, Y Xu, X Zhang, H Hu, W Xiao, Z Yu, T Sun… - Molecules, 2023 - mdpi.com
As a subclass of the biopharmaceutical classification system (BCS) class II, basic drugs
(BCS IIB) exhibit pH-dependent solubility and tend to generate supersaturation in the …

Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state

DM Mudie, K Murray, CL Hoad… - Molecular …, 2014 - ACS Publications
The rate and extent of drug dissolution and absorption from solid oral dosage forms is highly
dependent upon the volumes and distribution of gastric and small intestinal water. However …

Movement to the clinic of soluble epoxide hydrolase inhibitor EC5026 as an analgesic for neuropathic pain and for use as a nonaddictive opioid alternative

BD Hammock, CB McReynolds, K Wagner… - Journal of medicinal …, 2021 - ACS Publications
This report describes the development of an orally active analgesic that resolves
inflammation and neuropathic pain without the addictive potential of opioids. EC5026 acts …

Does oral apigenin have real potential for a therapeutic effect in the context of human gastrointestinal and other cancers?

EF DeRango-Adem, J Blay - Frontiers in pharmacology, 2021 - frontiersin.org
Apigenin (4′, 5, 7-trihydroxyflavone) is a plant flavone that has been found to have various
actions against cancer cells. We evaluated available evidence to determine whether it is …

[HTML][HTML] Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking …

SM Omar, F Ibrahim, A Ismail - Saudi Pharmaceutical Journal, 2020 - Elsevier
The aim of this study was the development of griseofulvin (GRI) loaded β-cyclodextrin (β–
CD) based nanosponges for bitter taste masking, improving dissolution rate and oral …

Improving solubility of poorly water-soluble drugs by protein-based strategy: A review

X Liu, L Zhao, B Wu, F Chen - International journal of pharmaceutics, 2023 - Elsevier
Poorly water-soluble drugs are frequently encountered and present a most challengeable
difficulty in pharmaceutical development. Poor solubility of drugs can lead to suboptimal …

pH-dependent solubility and dissolution behavior of carvedilol—case example of a weakly basic BCS class II drug

R Hamed, A Awadallah, S Sunoqrot, O Tarawneh… - Aaps Pharmscitech, 2016 - Springer
The objective of this study was to investigate the pH-dependent solubility and dissolution of
weakly basic Biopharmaceutical Classification Systems (BCS) class II drugs, characterized …

Diversity of β-cyclodextrin-based nanosponges for transformation of actives

S Pawar, P Shende, F Trotta - International journal of pharmaceutics, 2019 - Elsevier
Abstract β-Cyclodextrin-based nanosponges (β-CDNSs) play an important role in new
arrays of agriculture, floriculture, cosmetics, medicine, high molecular weight proteins, novel …